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Predicting the Progression of Palindromic
Rheumatism to Rheumatoid Arthritis: 
The Role of Ultrasonography and Anti-cyclic
Citrullinated Peptide Antibodies
Hsin-Hua Chen1,2,3, Der-Yuan Chen1,2,3*, Tsu-Yi Hsieh1,2, Guo-Dung Hung1, 
Howard Haw-Chang Lan4,5,6, Chia-Wei Hsieh1, Joung-Liang Lan1,2,3,7
We investigated whether sonography and anti-cyclic citrullinated peptide (anti-CCP) anti-
bodies in Chinese patients with palindromic rheumatism (PR) during active episodes are
of predictive value for development of rheumatoid arthritis (RA). Clinically involved
regions of 84 PR patients during active episodes were examined with ultrasonography
using a 6–13 MHz linear transducer. Serum levels of anti-CCP antibodies were deter-
mined by enzyme-linked immunosorbent assay. All patients were followed up monthly
for 3 years after investigation. Thirteen (15%) of the PR patients had progressed to RA
after a mean of 1.4 years (range, 0.4–3.0 years). Of these 13 patients, 11 patients (85%)
had sonographic features of synovitis and 8 patients (62%) had a positive anti-CCP anti-
body test. The absence of sonographic features of synovitis during active episodes pro-
vided a very high 3-year predictive value in excluding the possibility of progression to RA
for PR patients with a negative anti-CCP antibody test. Both the sonographic findings of
synovitis and a positive anti-CCP antibody test were significant predictors for progression
of PR to RA within 3 years by backward stepwise logistic regression analysis. Sonographic
examination together with an anti-CCP antibody test during active episodes is useful for
predicting the progression of PR to RA.
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Introduction
Palindromic rheumatism (PR) is characterized by
recurrent attacks of acute arthritis or periarticular
inflammation, lasting from a few hours to several
days with variable symptom-free intervals, and pro-
ducing no residual articular damage [1]. It is con-
troversial whether PR is a separate disorder or is a
prodrome of rheumatoid arthritis (RA). A number
of series of longitudinally followed-up PR patients
showed that one third to one half of these cases
evolved into RA [2–5]. Anti-cyclic citrullinated pep-
tide (anti-CCP) antibodies are highly specific for
RA [6], and appear to be much more predictive of
the development of RA than rheumatoid factor (RF)
[7,8]. Because recent reports highlight the early on-
set of structural articular damage in RA patients [9],
it could be important to separate PR patients from
those who have the potential to develop RA.
As distinct clinical, laboratory or radiological
markers have not yet been identified, the diagno-
sis of PR currently relies on clinical features and on
excluding other forms of episodic arthritis [10].
The recent availability of high-frequency transduc-
ers (> 7.5 MHz) allows sonographic approaches to
the diagnosis and assessment of soft tissue involve-
ment in patients with rheumatic diseases [11–13].
Kasukawa et al [14] reported that sonographic eval-
uation of synovial membrane proliferation in the
knee joints of two PR patients could be used to
identify conversion from PR to RA. Therefore, we
hypothesized that sonographic evaluation may help
predict the progression or non-progression of PR
to RA. However, there are no data on sonographic
findings of involved joints in a large number of PR
patients during active episodes.
In this study, we described the sonographic
findings of involved regions during active episodes
and determined serum anti-CCP levels in a cohort
of 84 unrelated Chinese PR patients. We followed
up these patients monthly for 3 years and investi-
gated whether sonographic findings and anti-CCP
antibodies during active episodes can be of predic-
tive values for determining the progression to RA
from PR.
Patients and Methods
This study was approved by the Ethics Committee
of Clinical Research at Taichung Veterans General
Hospital (VGHTC). From January to July 2003, we
recruited patients who fulfilled the diagnostic cri-
teria for PR as proposed by Guerne and Weismann
[10], and were suffering active episodes of PR as
determined by Dr. J.-L. Lan, D.-Y. Chen and T.-Y.
Hsieh at the rheumatology outpatient clinic of
VGHTC. When patients presented with acute on-
set of painful swelling over articular or periarticular
regions without preceding trauma, this was de-
fined as an active episode. Crystal arthritis and
infectious arthritis were excluded by synovial fluid
analysis if effusion was demonstrated by sono-
graphic examination. A total of 84 PR patients were
enrolled in this study. Thirty-two (38%) of these PR
patients were treated with hydroxychloroquine
only (200–400 mg daily) before their inclusion in
this study. Sixteen (19%) of the patients with PR
during active episodes had more than one region
of attack. We followed up the PR patients monthly
for 3 years at the outpatient clinic of VGHTC.
Antinuclear antibodies were screened by indi-
rect immunofluorescence using a Fluorhepana test
kit (Medical & Biological Laboratories Co. Ltd.,
Nagoya, Japan) with Hep-2 cells as the substrate.
The determination of anti-CCP antibody was per-
formed by enzyme-linked immunosorbent assay
using a commercial kit (INOVA Diagnostics Inc.,
San Diego, California, USA) [15]. A serum result
was considered positive for anti-CCP antibodies if
the titer was above 20 IU/mL. Serum levels of RF-
immunoglobulin M (IgM) and C-reactive protein
(CRP) were measured by nephelometry (Dade
Behring, Deerfield, Illinois, USA). A serum result
was considered positive for RF when the level was
above 22 IU/mL.
Sonographic assessment of the clinically involved
regions was performed with a General Electric
LOGIQ 500 unit (GE, Milwaukee, Wisconsin, USA)
using a 6–13 MHz linear array transducer. Gray-scale
ultrasonography (US) and power Doppler US (PDUS)
examinations of the involved regions during active
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episodes for PR patients were performed. The B-mode
frequency used was 11 MHz. The pulse repetition
frequency of PDUS was set at 1 KHz with a low
wall filter (150 Hz). The color gain of PDUS was
adjusted to a level just below that at which all
color noise disappeared from regions deep to the
cortical bone echo in the corresponding image.
Pulsed Doppler spectra were performed to confirm
the presence of vessels when the images were un-
clear. We followed the guidelines for patient posi-
tioning and standard scans that were advocated
by Backhaus et al in 2001 [16]. Assessment of local-
ized swelling or redness was carried out with longi-
tudinal and transverse planes to clarify its anatomy
and relation to adjacent structures. The adjacent
joint was also assessed circumferentially to detect
any associated pathology, especially synovitis. Bilat-
eral comparison was carried out. The scans were
performed by two rheumatologists (H.-H. Chen
and G.-D. Hong) who were trained and experienced
in musculoskeletal sonography. The examinations
of each patient were performed independently
and sequentially on the same day. Each sonogra-
pher was blinded to the laboratory findings, as
well as to the sonographic findings of the other
sonographer. They documented and stored digital
images of any abnormalities that were noted. All
ultrasound images were read in a blinded manner
by a radiologist (H.H.-C. Lan) and a rheumatolo-
gist (C.-W. Hsieh), who were both experienced in
musculoskeletal ultrasonography. The interpreta-
tion of the stored images was performed by con-
sensus between the two readers.
The images were interpreted as showing syn-
ovitis when effusion was present, or when an ab-
normal hypoechoic, intra-articular tissue that was
non-displaceable, poorly compressible and possi-
bly exhibiting Doppler signals was present within
any of the involved joint capsules. Doppler signals
were demonstrated in two planes and were con-
firmed by pulsed wave Doppler spectrum to exclude
artifacts. Effusion was characterized by abnormal
hypoechoic or anechoic intra-articular material that
was displaceable and compressible but did not ex-
hibit Doppler signals [17]. To test the consistency
of sonographic patterns in the same patient, 20 
patients were examined for a second time during
different active episodes in the 3 years following
the initial investigation.
Results are presented as the median [inter-
quartile (IQ) range] for age at onset, disease dura-
tion, and CRP levels. The χ2 test and Fisher’s exact
test were used for testing differences in the fre-
quencies of categorical data between groups. The
Mann-Whitney U test was used to test differences
in continuous variables between groups. Backward
stepwise logistic regression analysis was performed
to determine the optimal model for the prediction
of progression of PR to RA. A p value of less than
0.05 was considered to be significant. Statistical
calculations were performed using the SPSS ver-
sion 13.0 (SPSS Inc., Chicago, Illinois, USA).
Results
Fifty-two (62%) patients with PR did not receive
any medication for at least 3 months prior to en-
rollment in this study. Positive anti-CCP antibody
tests were observed in 11 (13%) patients with PR
during active episodes. Positive RF-IgM tests were
observed in 12 (14%) of patients with PR during
active episodes. CRP levels were increased in 54
(64%) patients with PR during active episodes. Low-
titer antinuclear antibodies (1:80–1:160) were found
in six (7%) PR patients during active episodes.
Radiographs of all involved locations showed an
absence of bony erosion or joint space narrowing.
Patients were divided into two groups based on
the presence or absence of sonographic features of
synovitis. Thirty (36%) PR patients had sonographic
features of synovitis in any of the involved regions
(Fig. 1). The remaining 54 (64%) PR patients dis-
played no sonographic features of synovitis in any
of the involved regions (Fig. 2). Extra-articular soft
tissue inflammation was observed in four of the 54
PR patients without synovitis (three over the left
sole and one over the right palm). The other 50 of
the 54 patients without synovitis had sonographic
findings of tenosynovitis (tendon sheath thickening
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that might exhibit Doppler signals in the involved
regions, 32 patients) and/or peri-articular soft tis-
sue inflammation (an abnormally thickened hypo-
echoic region over peri-articular soft tissue that
could potentially exhibit abnormal Doppler signals
compared with those exhibited in the correspon-
ding contralateral region, 26 patients). Doppler
signals were shown by PDUS in 66 (78%) of the 
84 PR patients. Joint effusion was shown in eight
(27%) of 30 PR patients who had sonographic
findings of synovitis. A thickened hypoechoic syn-
ovial membrane was found in 29 (97%) of these
patients. No evidence of bone erosion was demon-
strated in any PR patients.
A significantly higher positive rate of anti-CCP
antibody [26.7% vs. 5.6%, odds ratio (OR) 6.18,
95% confidence interval (CI) 1.50–25.52, p = 0.014]
and RF-IgM (30.0% vs. 5.6%, OR 7.29, 95% CI
1.79–29.60, p = 0.007) were observed in PR pa-
tients who had sonographic features of synovitis
compared with those in PR patients without sono-
graphic features of synovitis (Table 1). CRP levels in
PR patients with sonographic features of synovitis
were slightly higher than those in PR patients with-
out sonographic features of synovitis (median,
1.0 mg/dL, IQ range, 0.5–2.0 mg/dL vs. median,
0.8, IQ range, 0.3–1.2 mg/dL; p = 0.05). There were
no significant differences in age at onset, the pro-
portion of female, disease duration, frequency of
Doppler signals and the proportion of use of hydroxy-
chloroquine between PR patients with or without
sonographic features of synovitis (Table 1). There
was also no significant difference in the positive rate
of anti-CCP antibody and RF-IgM tests between PR
patients treated with hydroxychloroquine and those
in patients not treated with hydroxychloroquine
before inclusion in the present study.
CRP levels in PR patients whose PDUS images
exhibited abnormal Doppler signals were signifi-
cantly higher than those in PR patients whose PDUS
images did not exhibit these abnormal Doppler
signals (median, 1.0 mg/dL, IQ range, 0.7–1.6 mg/
dL vs. median, 0.2 mg/dL, IQ range, 0.1–0.3 mg/dL;
p < 0.001). CRP levels in PR patients who had sono-
graphic findings of synovitis with Doppler signals
in thickened synovium were also significantly higher
than those in PR patients who had sonographic
findings of synovitis without Doppler signals in
thickened synovium (median, 1.0 mg/dL, IQ range,
0.6–2.0 mg/dL vs. median, 0.37, IQ range, 0.24–
0.40 mg/dL; p = 0.007). There was no significant
difference in CRP levels between PR patients who
had sonographic features of synovitis with effusion
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Fig. 1. Sonographic image of the right wrist in a patient with
palindromic rheumatism with synovitis. Longitudinal scan
through the radius (R), lunate (L) and capitate (C) with a
gray-scale image. *Note an abnormally thickened hypoechoic
synovial membrane.
MCP
Fig. 2. Sonographic image of the second metacarpophalangeal
joint in a patient with palindromic rheumatism with peri-
articular inflammation from longitudinal scan on a standoff
pad with power Doppler image. Note the abnormally thick-
ened hypoechoic region (between the long arrows) and
Doppler signals over soft-tissue without involvement of the 
synovial membrane. MCP = metacarpophalangeal joint.
and PR patients who had sonographic features of
synovitis without effusion (median, 1.75 mg/dL, 
IQ range, 0.5–2.3 mg/dL vs. median, 1.00 mg/dL,
IQ range, 0.48–1.50 mg/dL; p = 0.396).
Twenty (24%) of the PR patients were available
to be examined for a second time during different
active episodes within a mean interval of 7.9 months
(range, 1–34 months). Nine (45%) of them had so-
nographic features of synovitis. Eighteen (95%) of
them had consistent sonographic patterns. In one
patient who had a negative anti-CCP antibody test
and had not progressed to RA during 3 years of
follow-up, the sonographic features shifted from
the presence of synovitis to the absence of synovi-
tis 7 months after the first US scan.
Thirteen (15%) of the PR patients had progressed
to RA after a mean of 1.4 years (range, 0.4–3.0 years).
Among them, 11 patients (85%) had sonographic
features of synovitis, 8 patients (62%) had positive
anti-CCP antibody tests and 8 patients (62%) had
positive RF-IgM tests. One patient who had a neg-
ative anti-CCP antibody test and absence of sono-
graphic features of synovitis progressed to systemic
lupus erythematosus. The remaining 70 PR patients
were treated with hydroxychloroquine 200–400 mg
daily unless remission lasted over 6 months.
The disease duration before investigation in PR
patients who had not progressed to RA was signif-
icantly longer than that in PR patients who had
progressed to RA (median, 7.0 years, IQ range,
4.0–12.0 years vs. median, 3.0 years, IQ range,
1.3–7.4 years; p = 0.008; Table 2). A significantly
higher rate of progression to RA was observed in
patients with sonographic features of synovitis com-
pared with that in patients without sonographic
features of synovitis (37.7% vs. 3.7%, OR 15.05,
95% CI 3.05–74.23, p < 0.001). A significantly
higher rate of progression to RA was also observed
in patients with positive anti-CCP antibody tests
than that in patients with negative anti-CCP anti-
body tests (72.7% vs. 6.8%, OR 36.27, 95% CI
7.26–181.06, p < 0.001). A significantly higher rate
of progression to RA was observed in patients with
positive RF-IgM tests compared with that in pa-
tients with negative RF-IgM tests (66.7% vs. 6.9%,
OR 26.80, 95% CI 5.95–120.76, p < 0.001). There
were no significant differences in the frequency of
presence of effusion and Doppler signals detected
by sonographic examinations, age at onset, the
proportion of females, the proportion of use of
hydroxychloroquine before investigation and CRP
levels between PR patients with progression to RA
and those in patients without progression to RA
(Table 2).
Of the 73 PR patients with negative anti-CCP
antibody tests, a significantly lower rate of pro-
gression to RA was observed in patients who had
no sonographic features of synovitis than that in
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Table 1. Clinical characteristics vs. ultrasonography findings in palindromic rheumatism patients*
Sonographic findings
Synovitis (–) (n = 54) Synovitis (+) (n = 30)
p OR (95% CI)
Age at onset (yr) 40 (29–44) 37 (28–50) 0.751
Sex (M:F)† 18:36 10:20 1.000 1.00 (0.39–2.58)
Disease duration (yr) 6.3 (3.9–11.8) 5.5 (2.8–10.6) 0.211
HCQ (+) (%)† 22 (40.7%) 16 (53.3%) 0.361 1.66 (0.68–4.09)
Doppler signal (+) (%)† 40 (74.1%) 26 (86.7%) 0.268 2.28 (0.67–7.68)
CRP (mg/dL) 0.8 (0.3–1.2) 1.0 (0.5–2.0) 0.050
CCP (+) (%)† 3 (5.6%) 8 (26.7%) 0.014 6.18 (1.50–25.52)
RF (+) (%)† 3 (5.6%) 9 (30.0%) 0.007 7.29 (1.79–29.60)
*Values are median (interquartile range) unless designated otherwise; †Fisher’s exact test. OR = odds ratio; CI = confidence interval; M = male; F = female;
HCQ = hydroxychloroquine; CRP = C-reactive protein; CCP = anti-cyclic citrullinated peptide antibody; RF = rheumatoid factor of Immunoglobulin 
M isotype.
patients who had sonographic features of synovitis
(0% vs. 29.4%, Table 3, p = 0.002). Of the 11 PR
patients with positive anti-CCP antibody tests, there
was no difference in the rate of progression to RA
between patients with sonographic features of syn-
ovitis and that in patients without sonographic
features of synovitis (Table 3).
The relative values of the presence of sono-
graphic features of synovitis, a positive anti-CCP
antibody test and a positive RF-IgM test in relation
to the subsequent development of RA within 3 years
are shown in Table 4. We used backward logistic re-
gression analysis to determine the optimal model
for the prediction of progression to RA within 3 years
(Table 5). In this analysis, the presence of sono-
graphic features of synovitis (OR 12.03, 95% CI
1.88–76.98, p = 0.009) and a positive anti-CCP anti-
body test (OR 3.74, 95%, CI 0.35–39.44, p < 0.001)
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Table 3. Associations between anti-cycle citrullinated antibody/sonographic findings during active episodes and
progression of palindromic rheumatism to rheumatoid arthritis (RA) within 3 years
Progression to RA
Yes No 
p OR (95% CI)
CCP (–)
Sonographic finding 0.002 –
Synovitis (+) 5 17
Synovitis (–) 0 51
CCP (+) 
Sonographic finding 1.000 1.50 (0.08–26.85)
Synovitis (+) 6 2
Synovitis (–) 2 1
OR = odds ratio; CI = confidence interval; CCP = anti-cyclic citrullinated peptide antibody.
Table 2. Clinical characteristics, and laboratory and sonographic findings for palindromic rheumatism patients
with and without progression to rheumatoid arthritis (RA)*
Progression to RA
Yes (n = 13) No (n = 71)
p OR (95% CI)
Age at onset (yr) 49 (25–55) 39 (28–43) 0.370
Sex (M:F) † 5:8 23:48 0.752 0.77 (0.23–2.60)
Disease duration (yr) 3.0 (1.3–7.4) 7.0 (4.0–12.0) 0.008
HCQ (+) (%)† 7 (40.7%) 16 (22.5%) 0.555 1.51 (0.46–4.93)
Sonographic findings
Synovitis (+)† 11 (84.6%) 19 (26.8%) < 0.001 15.05 (3.05–74.23)
Effusion (+)† 3 (23.1%) 5 (7.0%) 0.103 3.96 (0.82–19.19)
Synovial thickening (+) 11 (84.6%) 18 (25.4%) < 0.001 16.19 (3.27–80.11)
Doppler signal (+)† 10 (76.9%) 56 (78.9%) 1.000 0.89 (0.22–3.66)
CRP (mg/dL) 1.0 (0.4–2.6) 0.8 (0.4–1.2) 0.340
CCP (+) (%)† 8 (61.5%) 3 (4.2%) < 0.001 36.27 (7.26–181.06)
RF (+) (%)** 8 (61.5%) 4 (5.6%) < 0.001 26.80 (5.95–120.76)
*Values are median (interquartile range) unless designated otherwise; †Fisher’s exact test. OR = odds ratio; CI = confidence interval; M = male;
F = female; HCQ = hydroxychloroquine; CRP = C-reactive protein; CCP = anti-cyclic citrullinated peptide antibody; RF = rheumatoid factor of
Immunoglobulin M isotype.
were both significant variables for the prediction of
progression of PR to RA within 3 years. However,
the presence of sonographic findings of synovial
thickening, effusion, the presence of abnormal
Doppler signals detected by PDUS and a positive
RF-IgM test were excluded from the optimal model
for the prediction of progression of PR to RA within
3 years.
Discussion
To our knowledge, the present study is the first to
attempt to assess sonographic findings in a large
number of PR patients during active episodes. The
distribution of the joints involved in our patients
was similar to that in previous reports [1–5]. When
patients present clinically with swelling and red-
ness around the joint, it is often difficult to define
anatomic changes of the involved region by cli-
nical examination or conventional radiography.
Periarticular inflammation, which often presents
with swelling as well as redness and may involve
the joint structure, was observed in approximately
30% of PR patients in previous studies [1,5], whereas
a higher occurrence rate (64%) was shown by so-
nography in our PR patients. Consistent with the
findings of other reports [18–20], an improved
sensitivity in the detection of periarticular inflam-
mation using high-resolution US may have con-
tributed to this discrepancy between studies. In
the present study, the mean duration from onset
of symptoms to development of RA was 6.6 years.
Thirty (36%) of the PR patients in the present
study showed sonographic features of synovitis
(Fig. 2B). Twenty patients (87%) exhibited Doppler
signals in the thickened synovium on PDUS images.
The introduction of PDUS allows the detection of
smaller degrees of synovitis with a reported accu-
racy equal to that of dynamic MRI [21]. Using his-
topathology as gold standard, Koski et al [22] found
that a negative Doppler signal did not exclude the
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Table 4. Relative values of sonographic features of synovitis, anti-cyclic citrullinated peptide antibodies (CCP)
and rheumatoid factor during active episodes in predicting progression of palindromic rheumatism to
rheumatoid arthritis within 3 years
Synovitis (+) CCP (+) RF (+)
Synovitis (+) Synovitis (+) Synovitis (+) and 
or CCP (+) and CCP (+) CCP (+) and RF (+)
Sensitivity 0.85 0.62 0.62 1.00 0.46 0.46
Specificity 0.73 0.96 0.94 0.72 0.97 0.99
Positive predictive value 0.37 0.73 0.67 0.39 0.75 0.86
Negative predictive value 0.96 0.93 0.93 1.00 0.91 0.91
Positive likelihood ratio 3.16 14.56 10.92 3.55 16.39 32.77
Negative likelihood ratio 0.21 0.40 0.41 0 0.55 0.55
RF = rheumatoid factor of immunoglobulin M isotype.
Table 5. Results of backward stepwise logistic regression analysis for determination of the optimal model for the
prediction of progression of palindromic rheumatism to rheumatoid arthritis within 3 years
Significant variable OR (95% CI) p Excluded variables
Synovitis (+) 12.03 (1.88–76.98) 0.009 Synovial thickening (+)
CCP (+) 28.99 (4.52–185.91) < 0.001 Effusion (+)
Doppler signal (+)
RF (+)
OR = odds ratio; CI = confidence interval; CCP = anti-cyclic citrullinated peptide antibody; RF = rheumatoid factor of immunoglobulin M isotype.
possibility of synovitis and a positive Doppler signal
in the synovium was an indicator of an active syn-
ovial inflammation in patients. Moreover, a signifi-
cant correlation between the power Doppler signal
and the degree of vascularity of the synovial tissue
has recently been reported [23]. In our study, we
found significantly higher CRP levels in PR patients
with sonographic features of synovitis who had
Doppler signals in the synovium compared with
patients who did not have Doppler signals in the
synovium, and this could be because of the pres-
ence of more active synovial inflammation in these
patients.
There is no standard laboratory test to diagnose
PR. In our study, 54 (64.3%) of the patients with
PR had elevated CRP levels during active episodes.
The significantly higher CRP levels in PR patients
with sonographic features of synovitis compared
with patients without sonographic features of syn-
ovitis suggests a higher degree of inflammation in
synovitis. However, CRP is neither specific nor sen-
sitive enough for the diagnosis of PR. The lower
positive rate of anti-CCP antibodies in our patients
than those reported previously [8,24] may be due
to a longer mean ± SD disease duration (8.2 ± 6.4
years) before investigation in our PR patients (which
may have excluded some PR patients who pro-
gressed more rapidly to RA), and population char-
acteristics or target epitopes of citrulline used in
the detection method.
In the present study, a lower positive rate of anti-
CCP antibodies was found in patients with no sono-
graphic features of synovitis. In contrast, a higher
positive rate of anti-CCP antibodies was observed
in patients with sonographic features of synovitis.
Accumulating evidence suggests that the immune
response to citrullinated peptides could play a sig-
nificant role in the pathogenesis of synovitis in RA
[25,26]. However, this hypothesis needs to be con-
firmed by further investigation and a large prospec-
tive cohort study.
A longer disease duration was found in our PR
patients who had not progressed to RA compared
with that in patients who had progressed to RA.
However, the wide variation of duration from onset
to progression of PR to RA limits the use of disease
duration in predicting progression of PR to RA. Some
investigators have attempted to search for biologic
markers that might predict the progression to RA
in PR patients. Recently, a positive anti-CCP anti-
body test was found to be highly specific for RA
[6], and it appears to be much more predictive of
the development of RA than RF [7].
In the present study, we followed up our PR
patients for 3 years after US examinations and anti-
CCP antibody tests during active episodes. Only
15% of our PR patients had progressed to RA. The
rate of progression to RA in our PR patients is lower
than that reported previously [8,23]. This disparity
may be because of a longer disease duration
before investigation, population characteristics or
shorter duration of follow-up. However, the mean
duration (6.6 years) from onset of symptoms to
development of RA in our PR patients is consistent
with data reported previously [7,8].
The positive predictive value was 73% for a
positive anti-CCP antibody test in our study, which
is consistent with previous data [8]. The high
specificity and negative predictive values for a pos-
itive anti-CCP antibody test are also consistent
with previous reports [27,28]. We found that the
negative predictive value was high for both the
presence of sonographic features of synovitis and a
positive anti-CCP antibody test. We found that in
PR patients with a negative anti-CCP antibody 
test, there was a significantly lower rate of pro-
gression to RA in those patients without sono-
graphic features of synovitis compared with that 
in those with sonographic features of synovitis
(Table 3). The absence of sonographic features of
synovitis during active episodes provided a very
high 3-year predictive value in excluding the possi-
bility of progression to RA for PR patients with a
negative anti-CCP antibody test. In addition, we
used backward logistic regression analysis to deter-
mine the optimal model for the prediction of pro-
gression of PR to RA within 3 years and found that
both the presence of sonographic features of syn-
ovitis and a positive anti-CCP antibody test were
significant variables. Therefore, the sonographic
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findings of involved regions in PR patients during
active episodes could be valuable for helping clini-
cians to predict future development of RA within 
3 years.
Some limitations of our study should be high-
lighted. First, our study was conducted in ac-
cordance with daily clinical practice. Patients were
treated without hydroxychloroquine or with various
doses of hydroxychloroquine before recruitment
and during the 3-year follow-up period. Therefore,
we could not compare the predictive value of PDUS
variables depending on the medication received.
Second, we were not always able to perform US
scanning when patients presented active episodes;
we only performed US scanning when patients
happened to have active episodes during their
scheduled follow-up. Therefore, the data about
the consistency of the sonographic patterns in the
same patient were limited.
In conclusion, our results demonstrate that sono-
graphic examination, which is a quick, inexpensive,
and easily accessible technique for assessment of
synovial and periarticular tissues of PR patients dur-
ing active episodes, together with a test for anti-
CCP antibody are useful for predicting progression
to RA within 3 years.
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